Resources
Home
/
Resources
-
QuBAS Bioassay Software - Quantics in an App
Speaker Presentation Segall Jason Quantics - Bioassays Vendor Showcase 2023 -
In-vitro Expression Assay (IVE) for Potency Expression of mRNA Vaccine Product
Speaker Presentation Miteva Yana Pfizer 2023
-
Development of a Reporter Cell Line and Assay for Merck’s Ebola Vaccine (rVSV-∆G-ZEBOV-GP)
Speaker Presentation Meyer Brian Merck 2023
-
SVAR Life Science - Competence in Complement
Speaker Presentation Mayer Ulrich SVAR - Bioassays Vendor Showcase 2023
-
This is Sartorius - Simplifying Progress
Speaker Presentation Mangler Jason Sartorius - Bioassays Vendor Showcase 2023
-
Bioassays: The Superstars of Drug Development
Speaker Presentation Madden Helena bluebird bio 2023
-
EVUSHELD: Delivering Bioassay Methods and Critical Reagents Under Highly Accelerated Timelines from Clinical to Commercial phases
Speaker Presentation Machiesky Leann AstraZeneca 2023
-
Next-gen BLI for High Throughput Analytics
Speaker Presentation Levy Erik Gator Bio - Bioassays Vendor Showcase 2023
-
Potency Bioassays for Cell and Gene Therapy Products
Speaker Presentation Klinker Matthew FDA 2023
-
A New Application of Bioluminescence
for In-process Potency Testing of T Cell
Redirecting Viral Vectors
Speaker Presentation Gilden Julia Promega 2023
-
From Research to Market: the Evolving Assay Strategy of a Bispecific Antibody
Speaker Presentation Briguet Alexandre Roche 2023
-
Advantages and Challenges of Working with Non-ICH Countries
Speaker Presentation Thanaphollert Prapassorn FDA 2018 -
Conundrums in Biotechnology: How Does Quality Impact Safety?
Speaker Presentation Alexander G Caleb Johns Hopkins School of Public Health 2018
-
Overview of Regulatory Trends in Biological Products
Speaker Presentation Bai He China Food and Drug Administration 2018
-
Assessment Framework of Israel
Speaker Presentation Ben Naim Vered Israel Ministry of Health 2018
-
ICH Implementation at ANVISA
Speaker Presentation Bernardes Floreno Monica ANVISA 2018
-
FDA High-Level Update
Speaker Presentation Brunelle Joslyn FDA 2018
-
Development of Control Strategy for Vaccine Products
Speaker Presentation Campa Cristiana GlaxoSmithKline 2018
-
A Potential Innovative CMC Solution: Responding To Public Health Needs With An Accelerated Clinical Pathway–A Vaccine Example
Speaker Presentation Christian Natalie Merck, Co. Inc. 2018
-
A Regulatory Perspective on Integrated Control Strategy for Therapeutic Proteins
Speaker Presentation Damdinsuren Bazarrahchaa CDER, FDA 2018